Stockscreener 앱 받기
40.48
5.24%
-2.24
시간 외 거래:
40.55
0.07
+0.17%
전일 마감가:
$42.72
열려 있는:
$40.9
하루 거래량:
1.39M
Relative Volume:
1.13
시가총액:
$3.23B
수익:
-
순이익/손실:
$-237.22M
주가수익비율:
-10.71
EPS:
-3.78
순현금흐름:
$-212.64M
1주 성능:
-10.20%
1개월 성능:
-17.59%
6개월 성능:
+41.09%
1년 성능:
+60.25%
1일 변동 폭
$39.18
$41.12
1주일 범위
$39.18
$45.38
52주 변동 폭
$17.86
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
40.48 | 3.23B | 0 | -237.22M | -212.64M | -3.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Possible Bearish Signals With Akero Therapeutics Insiders Disposing Stock - simplywall.st
Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 6.3%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Proficio Capital Partners LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics (NASDAQ:AKRO) Shares Gap Up Following Insider Buying Activity - MarketBeat
How To Trade (AKRO) - news.stocktradersdaily.com
G. Walmsley Graham Acquires 50,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing - MarketScreener
Simplify Asset Management Inc. Sells 19,089 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Acquired by Swiss National Bank - Defense World
Akero Therapeutics director Graham Walmsley buys $8.79m in stock By Investing.com - Investing.com South Africa
Akero Therapeutics director Graham Walmsley buys $8.79m in stock - Investing.com India
Akero Therapeutics (AKRO) Stock Price, News & Analysis - MarketBeat
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Proficio Capital Partners LLC Invests $320,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Intech Investment Management LLC Buys 20,795 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Yiheng Capital Management L.P. Sells 92,624 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
There is no way Akero Therapeutics Inc (AKRO) can keep these numbers up - SETE News
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Alumis and Kaken sign agreement in Japan for ESK-001 - Pharmaceutical Technology
Charles Schwab Investment Management Inc. Acquires 8,096 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Investors to Connect - Markets Insider
Kennondale Capital Management LLC Acquires New Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Catriona Yale Sells 10,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Position Raised by Charles Schwab Investment Management Inc. - Defense World
Bank of New York Mellon Corp Sells 6,414 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Markets Insider
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by AlphaQuest LLC - MarketBeat
Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Sells 1,738 Shares of Stock - MarketBeat
How to Take Advantage of moves in (AKRO) - Stock Traders Daily
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $27,556.32 in Stock - MarketBeat
Akero therapeutics chief development officer sells $447,605 in stock By Investing.com - Investing.com Australia
Akero therapeutics chief development officer sells $447,605 in stock - Investing.com India
Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells $27,242.16 in Stock - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO William Richard White Sells 676 Shares - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.05%
1.79%
자본화:
|
볼륨(24시간):